Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

Comparison of Carboplatin Plus Pemetrexed Followed by Maintenance Pemetrexed With Docetaxel Monotherapy in Elderly Patients With Advanced Nonsquamous Non–Small Cell Lung Cancer

Published:2020-05-14 Issue:5 Volume:6 Page:e196828
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Okamoto Isamu¹,Nokihara Hiroshi²,Nomura Shogo³,Niho Seiji⁴,Sugawara Shunichi⁵,Horinouchi Hidehito⁶,Azuma Koichi⁷,Yoneshima Yasuto¹,Murakami Haruyasu⁸,Hosomi Yukio⁹,Atagi Shinji¹⁰,Ozaki Tomohiro¹¹,Horiike Atsushi¹²,Fujita Yuka¹³,Okamoto Hiroaki¹⁴,Ando Masahiko¹⁵,Yamamoto Nobuyuki¹⁶,Ohe Yuichiro⁶,Nakagawa Kazuhiko¹⁷

Affiliation:

1. Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

2. Department of Respiratory Medicine and Rheumatology, Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan

3. Japan Clinical Oncology Group (JCOG) Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan

4. Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba, Japan

5. Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan

6. Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan

7. Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, Fukuoka, Japan

8. Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka, Japan

9. Department of Thoracic Oncology and Respiratory Medicine, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan

10. Department of Thoracic Oncology, National Hospital Organization Kinki-chuo Chest Medical Center, Osaka, Japan

11. Division of Medical Oncology, Kishiwada City Hospital, Osaka, Japan

12. Department of Thoracic Medical Oncology, The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan

13. National Hospital Organization Asahikawa Medical Center, Asahikawa, Japan

14. Department of Respiratory Medicine, Yokohama Municipal Citizen’s Hospital, Kanagawa, Japan

15. Center for Advanced Medicine and Clinical Research, Nagoya University Hospital, Nagoya, Japan

16. Internal Medicine III, Wakayama Medical University, Wakayama, Japan

17. Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2762583/jamaoncology_okamoto_2020_oi_190117.pdf

Reference20 articles.

1. Challenge of cancer in the elderly.;Marosi;ESMO Open,2016

2. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer.;The Elderly Lung Cancer Vinorelbine Italian Study Group;J Natl Cancer Inst,1999

3. Phase III study of docetaxel compared with vinorelbine in elderly patients with advanced non-small-cell lung cancer: results of the West Japan Thoracic Oncology Group trial (WJTOG 9904).;Kudoh;J Clin Oncol,2006

4. Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial.;Gridelli;J Natl Cancer Inst,2003

5. A phase II study of cisplatin and docetaxel administered as three consecutive weekly infusions for advanced non-small-cell lung cancer in elderly patients.;Ohe;Ann Oncol,2004

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Geriatric oncology in the most aged societies;Japanese Journal of Clinical Oncology;2024-07-22

2. A Case of ROS1-Fusion Non-Small Cell Lung Cancer with Acquired BRAF Mutation Developing Unusual Skin Metastasis;Clinical Lung Cancer;2024-06

3. Integrated analysis of older adults and patients with renal dysfunction in the IMpower130 and IMpower132 randomized controlled trials for advanced non-squamous non-small cell lung cancer;Lung Cancer;2024-06

4. Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE Trial;Clinical Lung Cancer;2024-05

5. Brief report: Carboplatin, weekly Paclitaxel and Pembrolizumab in elderly patients for advanced Non-Small Cell Lung Cancer with PD-L1<50%: real-world data.;Clinical Lung Cancer;2024-05